Each month, we take a look back at the most popular Oncology Nursing News stories. Here are the top 5 stories from June 2020.
Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from June 2020.
5. Better Palliative Care Integration Needed for Clinical Trial Participants
Take a closer look at a recent study presented at the 2020 ASCO Virtual Scientific Meeting, which showed that patients on phase I clinical trials tended to have improved quality of life outcomes when they received palliative care.
4. Helping Breast Cancer Survivors Deal With Body Image Issues
As a nurse and patient advocate, helping the patient find the right self-care balance after breast cancer treatment is vital to helping a woman maintain her self-image. Here, an expert offers tips on how to help your patients by seeking external resources such as Walgreens’ “Feel More Like You” program.
3. Upfront 4-Drug Regimen Is Tolerable in Lung Cancer Treatment
The 4-drug combination of atezolizumab (Tecentriq), bevacizumab (Avastin), carboplatin, and paclitaxel (ABCP) improved survival while maintaining good health-related quality of life in patients with nonsquamous non—small cell lung cancer, according to patient-reported outcomes (PROs) from the phase 3 IMpower150 trial.
2. Nurses Unlock Role in Cancer Genetics
In our latest cover story, we take a closer look at how nurses in the field of oncology are specializing in new roles in cancer genetics to not only counsel existing patients, but also play a role in cancer prevention as well.
1. Not ‘Just a Nurse’
With the COVID-19 pandemic magnifying the value of real-world data in oncology, check out this story on how the FDA is spearheading several initiatives aimed at refining the role of this data in cancer care to guide clinical trial development and find answers to pressing questions.
Thanks for reading!
Maintained QOL, Neurological Function Support T-DXd Safety and Efficacy in HER2+ mBC
December 20th 2024In line with its safety and efficacy profile, T-DXd preserved quality of life and neurological function in patients with HER2-positive metastatic breast cancer, irrespective of brain metastases.